UHRF1 and gastric cancer: Through bioinformatics analysis, we found that miR-506 has a potential binding site on UHRF1. Related studies have reported that miR-506 targets ZEB2 to inhibit gastric cancer invasion and is associated with the poor prognosis of gastric cancer (Wang et al., 2019).